Basal Cell Carcinoma

Abstract illustration of basal cell carcinoma

Overview

Basal cell carcinoma (BCC) is a cancer that starts in the basal cells, the round cells in the lower part of the outer layer of the skin1. It is the most common form of cancer in the United States, is most common after age 50, and almost always grows slowly2. Treatment is usually surgery or another local treatment, chosen according to the risk that the cancer will come back3.

Emergency warning signs

Where it starts

The outer layer of the skin contains flat squamous cells near the surface and round basal cells beneath them. Basal cell carcinoma and squamous cell carcinoma are the most common types of skin cancer, while melanoma is less common1. Melanoma and the other types are compared on the skin cancer page.

How common it is

BCC is the most common form of human cancer, and the number of new cases in the United States keeps rising each year3. It is most common in people over 50 but can also appear in younger people who have had a lot of sun exposure2.

Who is at risk

The main risks are long-term exposure to sunlight and a fair complexion: fair skin that freckles and burns easily and tans poorly, light-colored eyes, and red or blond hair. Other risk factors include a history of sunburns, inherited syndromes such as basal cell nevus syndrome, skin inflammation that lasts a long time, a weakened immune system, exposure to arsenic, and past radiation treatment. A fair complexion raises the risk, but people of all skin colors can get skin cancer1. Close relatives with skin cancer, many severe sunburns early in life, long-term daily sun exposure such as from working outdoors, many moles, and medicines that suppress the immune system after an organ transplant also raise the risk2.

What it looks like

BCC usually grows slowly, is often painless, and may not look very different from normal skin at first. Some are only slightly raised or even flat2. The table shows the forms it most often takes1,2:

Common appearances of basal cell carcinoma1,2
AppearanceWhat you might notice
BumpPearly or waxy; white, light pink, flesh-colored, or brown
PatchA red, scaly area of skin
Scar-like areaFirm and white, yellow, or waxy, without an injury to explain it
SoreBleeds easily, oozes or crusts, or does not heal

Where it appears

It occurs most often on skin exposed to the sun, such as the nose, ears, lower lip, or the backs of the hands. Not every skin change is cancer, but any change is worth checking with a doctor1.

Emergency

Emergency warning signs

Check with a doctor if you notice1:

  • A sore that does not heal:

    Especially on the face, ears, or hands.

  • A pearly or shiny bump:

    A raised, smooth bump that looks pearly or waxy.

  • A spot that bleeds or crusts:

    Skin that is scaly, bleeding, or crusty without a clear cause.

Call 911

Skin exam and biopsy

Doctors use tests and procedures that examine the skin to diagnose BCC1, and a piece of the suspicious skin must be removed and checked under a microscope, called a skin biopsy, to confirm it2.

Low-risk and high-risk tumors

BCC has no formal staging system. Instead, doctors sort tumors by their risk of coming back, based on features such as size, location, and how the cancer cells look, and this risk guides the choice of treatment3.

Choosing a treatment

Surgery is the most effective treatment for most BCCs3. The choice depends on the size, depth, and location of the cancer and on your overall health2.

Main treatments for basal cell carcinoma1,3
TreatmentWhen it is used
Curettage and electrodesiccation (scraping and heat)Low-risk tumors in areas without thick terminal hair
Surgical excision with 4-mm marginsLow-risk tumors, with the edges checked under a microscope
Mohs micrographic surgeryHigh-risk tumors, removing thin layers and checking each one until no cancer remains; also used when BCC comes back
Imiquimod or 5-fluorouracil cream, photodynamic therapy, cryosurgery, or radiationWhen surgery is not possible or not preferred; cure rates may be lower than with surgery
Vismodegib or sonidegib (targeted pills)BCC that has spread or cannot be treated with local therapy

Matching treatment to the location

Mohs surgery is often used for cancers on the nose, ears, and other parts of the face, where saving healthy skin matters. Freezing, creams, and light therapy are used for cancers that are not large or deep, and radiation may be used when surgery is not an option2.

Advanced BCC

For BCC that has spread or cannot be treated locally, targeted pills such as vismodegib or sonidegib, or a clinical trial of a new treatment, may be offered. Laser surgery is rarely used1.

Treatments with limited evidence

U.S. dermatology guidelines found too little evidence to recommend laser treatment or electronic surface brachytherapy, a form of targeted radiation, for routine use against BCC3.

Lowering your risk

After a BCC, dermatologists recommend learning to examine your own skin and protecting it from the sun3. Everyday sun protection steps are covered on the skin cancer page.

As of October 2026, based on sources checked October 31, 2026. See References

What we know

  • Recommended by guidelines

    Surgery is the most effective treatment for most BCCs.

    Why it matters:

    U.S. dermatology guidelines prefer surgical options and reserve other treatments for when surgery is not feasible3.

  • Recommended by guidelines

    Mohs surgery is recommended for high-risk BCC.

    Why it matters:

    It checks every edge of the removed tissue, which matters most for tumors likely to come back3.

What we don't know yet

  • Uncertain

    How much less effective non-surgical treatments are.

    Why it matters:

    Guidelines say cure rates may be lower with creams, light therapy, freezing, or radiation, but the size of the gap varies3.

  • Uncertain

    How to stage BCC precisely.

    Why it matters:

    There is no formal staging system, so treatment decisions rely on a risk-of-recurrence grouping3.

Is basal cell carcinoma a serious cancer?

It is a true cancer, but it rarely spreads to other parts of the body. Squamous cell carcinoma, the other common skin cancer, is more likely to invade nearby tissue and spread. BCC that does spread or cannot be removed is treated with targeted pills1.

Does nicotinamide prevent basal cell carcinoma?

It may help some people, but not everyone. In a trial of 386 people who had already had at least 2 nonmelanoma skin cancers, nicotinamide 500 mg twice daily for a year lowered new skin cancers by 23%, although the drop for BCC alone (20%) was not statistically certain, and the benefit faded after stopping4. In organ transplant recipients, the same dose did not reduce new skin cancers5.

Can basal cell carcinoma come back?

Yes. A past BCC is a risk factor for developing another skin cancer1, so people who have had one should have a skin cancer screening at least once a year3.

Do tanning beds cause basal cell carcinoma?

They can contribute. Artificial ultraviolet light from tanning beds counts as a recognized risk factor for basal cell carcinoma when exposure adds up over many years, just like natural sunlight1. Reasons to avoid tanning beds are explained on the skin cancer page.

Sources checked

  1. National Cancer Institute. Skin cancer treatment (PDQ): patient version (opens in a new tab)
    cancer.gov · May 1, 2025 · Health agency · Accessed October 31, 2026 · Back: a b c +10
  2. National Library of Medicine (MedlinePlus). Basal cell skin cancer (opens in a new tab)
    MedlinePlus Medical Encyclopedia · August 2, 2025 · Health agency · Accessed October 31, 2026 · Back: a b c +6
  3. Bichakjian C, Armstrong A, Baum C, et al. Guidelines of care for the management of basal cell carcinoma (opens in a new tab)
    J Am Acad Dermatol. 2018;78(3):540-559 · Guideline · Accessed October 31, 2026 · Back: a b c +9
  4. Chen AC, Martin AJ, Choy B, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention (opens in a new tab)
    N Engl J Med. 2015;373(17):1618-1626 · Study · Accessed October 31, 2026 · Back: a
  5. Allen NC, Martin AJ, Snaidr VA, et al. Nicotinamide for skin-cancer chemoprevention in transplant recipients (opens in a new tab)
    N Engl J Med. 2023;388(9):804-812 · Study · Accessed October 31, 2026 · Back: a

The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.